Ketek liver damage
Greg Jones Law has a demonstrated record of results in pharmaceutical litigation. We have advocated for clients through individual lawsuits and class actions, representing clients nationwide. We will aggressively pursue your fair and timely compensation. Contact us today.
Ketek is the trade name for telithromycin, an antibiotic once widely used to treat pneumonia, bacterial bronchitis and sinusitis. (The FDA has since withdrawn its approval for treatment of sinusitis or bronchitis, and now restricts Ketek to treating certain types of pneumonia.)
After twice rejecting Ketek for safety concerns, the FDA approved Ketek for use in the United States in 2004. After hundreds of reports of side effects, including dozens of cases of severe or fatal side effects, the FDA required a “black box” warning in 2006. Even then, Sanofi-Aventis dragged its feet for many months before adding the warning to its label.
Despite the ample evidence of wrongdoing by the manufacturer, unscrupulous doctors and FDA insiders, you or your loved one must have suffered
severe liver damage or other substantial harm from Ketek to bring a claim:
- Liver failure and health complications
- Hospitalization for hepatitis
- Liver damage requiring a liver transplant
- Liver failure resulting in death
- Heart failure
- Chronic colon inflammation
Our role is to detail the adverse health effects, establish the connection to Ketek, and calculate appropriate damages, such as for medical care, nursing care, lost income, lost quality of life, and pain and suffering.
